Therefore, based on these findings, increasing irisin levels and upregulating browning and beiging of WAT can be a new therapeutic strategy to treat obesity and improve insulin sensitivity to prevent GDM in overweight and obese pregnant women. This evidence concerns the gene INS and obesity disorder.